reta with cagrilintide GLP-3R / CAG 12.5MG / 2.5MG Retatrutide Cagrilintide Blend Peptide |

Step 2 Review Process After receiving the data provided in the questionnaire, they will go through a review process by our specialists who will determine if you are eligible or not to comply with the treatment

Not for human or animal consumption, injection, diagnosis, treatment, or therapeutic application.

KPV is a tripeptide made of lysine, proline, and valine, corresponding to the C-terminal segment of alpha-melanocyte-stimulating hormone (-MSH)

For a 0.5mg (500mcg) dose: 500 / 2,500 x 100 = 20 units

The peptides effects on spinal cord injuries are supported by a growing body of evidence, indicating its potential as a groundbreaking treatment option